From a mechanistic perspective, the therapeutic effect of SCFAs in treating arrhythmias caused by sepsis is attributed to their antibacterial effect against C. sakazakii, but the involvement of SCFAs-related receptors, such as FFAR2 and FFAR3, also plays an important role. The gene discussed is FFAR2; the disease is cardiac arrhythmia.